PExA granted two US patents

Pexa, a small research company whose stock is traded on Spotlight, has just had two new US patents approved for its non-invasive PExA small airway biomarker detection instrument.

One of them is called “System for collecting exhaled particles” and has already been approved in Europe, Japan and Sweden. The granted patent in the US is part of PExA’s ongoing efforts to protect its various technologies.

The second patent “Device and method for non-invasive analysis of particles during medical ventilation” which is an invention relating to continuous diagnosis and monitoring of patients during ventilation or breathing. The patent is aimed at continuous diagnosis and monitoring of patients undergoing ventilator or ventilator therapy.

The granted patent in the US, which is valid until 2035, is part of PExA’s ongoing efforts to protect its various technologies.

With Viking’s signals, you have a good chance of finding the winners and selling in time. There are many securities. With Viking’s autopilots or tables, you can sort out the most interesting ETFs, stocks, options, warrants, funds, etc.

Click here to see what Vikingen offers: Detailed Comparison – Stock exchange software for those who want to become even richer (vikingen.se)